CROSSROADS STRATEGIES, LLC

Lobbying for VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA AG · global pharmaceutical company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $50,000.00 income · posted Jul 20, 2025

Lobbying activity 2

Medicare/Medicaid

General education about end stage renal disease (ESRD) and kidney disease policies, including Medicare beneficiary access to pharmaceuticals.

Health Issues

General education about end stage renal disease (ESRD) and kidney disease policies.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.